Literature DB >> 18537622

From a dull enzyme to something else: facts and perspectives regarding aldose reductase.

A Del Corso1, M Cappiello, U Mura.   

Abstract

Aldose Reductase (ALR2) is defined as the first enzyme of the "polyol pathway". As such, ALR2 would convert glucose to sorbitol through an NADPH dependent reaction. Considered a promoter of osmotic imbalance under hyperglycemic conditions, the enzyme has been under intense investigation as a critical target to prevent and control diabetic complications through the inhibition of its activity. Further characterization of ALR2 suggests its participation in cell detoxification mechanisms through the reduction of toxic aldehydes. Moreover, intriguing is the apparent involvement of the enzyme in the signalling machinery of inflammatory cell response. Here, the structural and functional assessment of ALR2 as an aldose/aldehyde reducing enzyme, and its involvement in various aspects of cell function from sugar metabolism to redox homeostasis and cell signaling are presented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537622     DOI: 10.2174/092986708784638870

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  28 in total

1.  Label-free protein profiling of adipose-derived human stem cells under hyperosmotic treatment.

Authors:  Elizabeth S Oswald; Lewis M Brown; J Chloë Bulinski; Clark T Hung
Journal:  J Proteome Res       Date:  2011-06-14       Impact factor: 4.466

Review 2.  How the chemical features of molecules may have addressed the settlement of metabolic steps.

Authors:  Antonella Del-Corso; Mario Cappiello; Roberta Moschini; Francesco Balestri; Umberto Mura
Journal:  Metabolomics       Date:  2017-11-20       Impact factor: 4.290

3.  Antioxidant action of 3-mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid, an efficient aldose reductase inhibitor, in a 1,1'-diphenyl-2-picrylhydrazyl assay and in the cellular system of isolated erythrocytes exposed to tert-butyl hydroperoxide.

Authors:  Marta Soltesova Prnova; Jana Ballekova; Magdalena Majekova; Milan Stefek
Journal:  Redox Rep       Date:  2015-06-11       Impact factor: 4.412

4.  Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetes.

Authors:  Sirilaksana Kunjara; A Leslie Greenbaum; Milena Sochor; Allan Flyvbjerg; Henning Grønbaek; Patricia McLean
Journal:  Int J Exp Pathol       Date:  2014-03-06       Impact factor: 1.925

5.  Early hepatic insulin resistance in mice: a metabolomics analysis.

Authors:  Lei O Li; Yun-Fu Hu; Lily Wang; Matthew Mitchell; Alvin Berger; Rosalind A Coleman
Journal:  Mol Endocrinol       Date:  2010-02-11

6.  Protective effect of Pterocarpus marsupium bark extracts against cataract through the inhibition of aldose reductase activity in streptozotocin-induced diabetic male albino rats.

Authors:  YanLi Xu; Yongxia Zhao; YaNan Sui; XiaoJun Lei
Journal:  3 Biotech       Date:  2018-03-19       Impact factor: 2.406

7.  Featured Article: Inhibition of diabetic cataract by glucose tolerance factor extracted from yeast.

Authors:  Nitsa Mirsky; Revital Cohen; Anat Eliaz; Ahuva Dovrat
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-28

8.  Structure of aldose reductase from Giardia lamblia.

Authors:  M Ferrell; J Abendroth; Y Zhang; B Sankaran; T E Edwards; B L Staker; W C Van Voorhis; L J Stewart; P J Myler
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-08-16

9.  Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract.

Authors:  Milan Stefek
Journal:  Interdiscip Toxicol       Date:  2011-06

Review 10.  Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.

Authors:  Lucia Kovacikova; Marta Soltesova Prnova; Magdalena Majekova; Andrej Bohac; Cimen Karasu; Milan Stefek
Journal:  Molecules       Date:  2021-05-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.